Plain-English translation of NCT07036965 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different pulsed field ablation catheters — CardiPulse and FaraPulse — to treat atrial fibrillation, a condition where your heart beats irregularly. Both devices use electrical pulses (instead of heat) to fix the problem areas in your heart. The study wants to see which catheter works better and is safer for patients who have a high risk of stroke.
Pulsed field ablation is a newer technique that may cause less swelling and damage to heart tissue after treatment compared to older methods. However, no large study has yet compared which pulsed field catheter works best, so doctors need this information to know which one to recommend.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive a catheter ablation procedure using one of the two pulsed field catheters (decided randomly). The procedure involves inserting a thin tube into a blood vessel and guiding it to your heart to fix the irregular heartbeat areas. You will also receive treatment to prevent blood clots in your heart. After the procedure, you will have follow-up visits and monitoring to check how well the treatment worked and whether you experience any side effects.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
China